ANI Pharmaceuticals IncNASDAQ:ANIP
- LAST PRICE66.1400
- TODAY'S CHANGE (%)0.5200 (0.7924%)
- Bid / Lots63.8000/ 1
- Ask / Lots67.5700/ 1
- Open / Previous Close65.9000 / 65.6200
- Day Range
- 52 Week Range
- Volume85,940
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ANIP |
|---|---|---|
| 09:32 ET | 576 | 65.9 |
| 09:45 ET | 561 | 65.51 |
| 09:59 ET | 100 | 65.975 |
| 10:03 ET | 100 | 66.08 |
| 10:10 ET | 100 | 66.18 |
| 10:12 ET | 200 | 66.11 |
| 10:24 ET | 300 | 66.18 |
| 10:32 ET | 100 | 66.41 |
| 10:35 ET | 150 | 66.3889 |
| 10:37 ET | 100 | 66.51 |
| 10:39 ET | 300 | 66.37 |
| 11:00 ET | 200 | 66.39 |
| 11:06 ET | 200 | 66.39 |
| 11:08 ET | 400 | 66.39 |
| 11:11 ET | 500 | 66.295 |
| 11:18 ET | 100 | 66.325 |
| 11:33 ET | 1100 | 66.04 |
| 11:40 ET | 100 | 66.2 |
| 11:45 ET | 203 | 66.115 |
| 11:51 ET | 100 | 66.16 |
| 11:58 ET | 500 | 65.995 |
| 12:00 ET | 200 | 66.01 |
| 12:02 ET | 100 | 65.95 |
| 12:16 ET | 300 | 66.025 |
| 12:25 ET | 200 | 66.14 |
| 12:27 ET | 600 | 66.21 |
| 12:32 ET | 100 | 66.21 |
| 12:39 ET | 1407 | 66.14 |
| 12:41 ET | 1000 | 66.12 |
| 12:59 ET | 200 | 66.15 |
| 01:03 ET | 100 | 66.065 |
| 01:19 ET | 100 | 66.32 |
| 01:26 ET | 100 | 66.3275 |
| 01:35 ET | 800 | 66.37 |
| 01:37 ET | 100 | 66.51 |
| 01:39 ET | 200 | 66.465 |
| 01:46 ET | 300 | 66.7 |
| 01:48 ET | 100 | 66.9 |
| 01:51 ET | 300 | 66.66 |
| 01:53 ET | 456 | 66.675 |
| 02:00 ET | 100 | 66.765 |
| 02:02 ET | 100 | 66.695 |
| 02:08 ET | 200 | 66.63 |
| 02:15 ET | 100 | 66.74 |
| 02:26 ET | 100 | 66.77 |
| 02:27 ET | 400 | 66.64 |
| 02:42 ET | 4000 | 66.29 |
| 02:44 ET | 100 | 66.475 |
| 02:51 ET | 100 | 66.43 |
| 03:03 ET | 1384 | 66.25 |
| 03:05 ET | 100 | 66.17 |
| 03:20 ET | 100 | 66.235 |
| 03:25 ET | 100 | 66.31 |
| 03:36 ET | 204 | 66.26 |
| 03:39 ET | 600 | 66.24 |
| 03:43 ET | 100 | 66.17 |
| 03:48 ET | 100 | 66.15 |
| 03:50 ET | 100 | 66.13 |
| 03:52 ET | 703 | 66.24 |
| 03:54 ET | 2014 | 66.22 |
| 03:56 ET | 900 | 66.27 |
| 03:57 ET | 200 | 66.22 |
| 03:59 ET | 1900 | 66.14 |
Today
Apr 18, 2024
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET, from 4:05PM ET on Thursday Apr 18, 2024 by Dow Jones
4:05PM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 9, 2024
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension, from 6:50AM ET on Tuesday Apr 09, 2024 by Dow Jones
6:50AM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 4, 2024
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis, from 6:50AM ET on Thursday Apr 04, 2024 by Dow Jones
6:50AM ET on Thursday Apr 04, 2024 by Dow Jones
Apr 3, 2024
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium, from 6:50AM ET on Wednesday Apr 03, 2024 by Dow Jones
6:50AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ANI Pharmaceuticals Inc | 1.4B | 80.6x | -8.16% |
Collegium Pharmaceutical Inc | 1.1B | 40.7x | --- |
Taro Pharmaceutical Industries Ltd | 1.6B | 34.7x | -33.66% |
Tilray Brands Inc | 1.3B | -3.7x | --- |
Harmony Biosciences Holdings Inc | 1.7B | 13.5x | --- |
Corcept Therapeutics Inc | 2.3B | 24.1x | +9.80% |
Company Information
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of 116 products with a variety of indications and a robust portfolio of pipeline products. It has acquired the NDAs for and market Atacand, Atacand HCT, Arimidex, Casodex, Lithobid, Vancocin, Inderal LA, Inderal XL, InnoPran XL, Oxistat, Veregen, and Pandel. The Company sources the raw materials for its products from both domestic and international suppliers.
Contact Information
- Headquarters
- 210 Main Street WestBAUDETTE, MN, United States 56623
- Phone
- 218-634-3500
- Fax
- 218-634-3540
Executives
- Independent Chairman of the Board
- Patrick Walsh
- President, Chief Executive Officer, Director
- Nikhil Lalwani
- Chief Financial Officer, Senior Vice President
- Stephen Carey
- Chief Human Resource Officer
- Krista Davis
- Senior Vice President, General Counsel, Company Secretary
- Meredith Cook
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $486.8M |
Shares Outstanding | 21.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.81 |
EPS | $0.82 |
Book Value | $22.35 |
P/E Ratio | 80.6x |
Price/Sales (TTM) | 2.8 |
Price/Cash Flow (TTM) | 17.9x |
Operating Margin | 9.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
